Skip to content
Search

Latest Stories

Follow Us:
Top Stories

28 miles to the nearest pharmacy? For many, that's the only option.

Closed pharmacy

Pharmacies are closing all across the United States.

J. Michael Jones/Getty Images

Pharmacies in the United States are closing at an alarming rate. The ACT Pharmacy Collaborative, a partnership between community pharmacy networks and academia, reported that 244 pharmacies closed in just the first six weeks of 2024. Similarly, Rite-Aid has closed 500 stores, CVS will close another 300 stores by the end of the year and Walgreens will close 1,200 over the next three years.

In my home state of Oregon, pharmacists are constantly facing untenable scenarios. At a recent hearing, a pharmacist from a rural community testified how a woman from a neighboring town called his pharmacy late in the day needing to urgently fill a prescription. Unfortunately, the only pharmacy in her town had permanently closed, so she was stuck frantically attempting to locate someone who took their insurance and had the medication in stock. His pharmacy had the medication, so while she drove 28 miles on rural roads, the pharmacy stayed open — 30 minutes after closing because that’s what pharmacists do. We take care of patients.


Afterwards, when the patient had the medication in hand and was counseled on how to use it correctly, the pharmacist checked to see how much was made from the prescription. To his dismay, in the end, the pharmacy was reimbursed $23 below the drug’s acquisition price. His pharmacy lost money for taking care of a patient that evening.

Now it might be easy to chalk this up as an isolated incident — an unfortunate anomaly or glitch in our health care system. However, instances like this happen on a regular basis and it has become commonplace to have a prescription reimbursed at an amount that is less than the cost to acquire and dispense the drug. Given the high cost of medications, this may come as a surprise. However, pharmacy benefit managers currently have an outsized influence on the financial health of many community pharmacies.

PBMs are middlemen — often invisible to the patient — that are located at the interface of drug manufacturers, payers and their employer-sponsors, and community pharmacies. They began over 50 years ago as a solution to help payers manage the complexity of prescription drug benefits. PBMs were highly efficient at claims processing, and they do play a role in helping payers process a high volume of relatively small claims. However, over time, the role of PBMs has evolved and expanded to where PBMs are now engaged in negotiating drug prices and determining which medications are covered by a plan’s formulary. They also operate their own pharmacies through closely affiliated partners. This gives PBMs considerable influence on how much pharmacies are paid, which drugs are covered and where patients can fill their prescriptions.

Simultaneously, over time, the PBM market has become highly concentrated. A report released by the Federal Trade Commission in July found that in 2023 the three largest PBMs companies processed approximately 80 percent of the prescriptions dispensed by U.S. pharmacies and that percentage rises to 90 percent if expanding to the six largest PBMs. All the major players are now vertically integrated with other parts of the health sector, often resulting in massive conglomerates where PBMs simultaneously play the role of plan, pharmacy and middleman. The FTC report highlights how PBMs impose “confusing, unfair, arbitrary, and harmful” contractual terms that influence the financial health of pharmacies.

PBMs have grown in such a way that it makes it nearly impossible for the average consumer — or even seasoned policy maker — to understand the problems and propose solutions. And when things are confusing, it is easy to become paralyzed and do nothing. However, in this case, doing nothing is simply not an option. Pharmacies are in crisis. The pharmacy from above has since closed, leaving another rural Oregon town with one less access point for patients.

Momentum for federal regulation that will bring more transparency and accountability to how PBMs influence the drug supply chain has built over the last few years. Multiple bills have come out of congressional committees with unanimous bipartisan support. The chairman of the Senate Finance Committee, Sen. Ron Wyden (D-Ore.), and high-ranking Republicans have expressed support for PBM reform. Congress has now returned to Washington, creating a final and crucial opportunity to pass PBM reform in 2024. It must be done.

To be sure, as a pharmacist, I care deeply about my profession. However, I care even more deeply about the patients that my profession serves. It saddens me that if PBM reform does not pass, then many more pharmacies will close, and more communities will lose pharmacy access. It saddens me that people residing in those communities might need to hold their breath, cross their fingers and hope they are not the patient needing a pharmacy to stay open past close as they drive those 28 miles.

Irwin is a clinical associate professor at Oregon State University’s College of Pharmacy and a public voices fellow with The OpEd Project. She is also a former president of the Oregon State Pharmacy Association.


Read More

two cars on a highway
Cars drive on a highway next to a river

Why Your Town’s Roads Run Through Washington: Unpacking Transportation Infrastructure Funding

Introduction

Access to reliable transportation is a critical part of most Americans’ daily lives. In 2022, Americans took an average of 2.28 trips per day, traveling 28.55 miles on average — figures including every mode of transportation and every purpose, for the full population. However, little attention is paid to transportation infrastructure until there are obvious problems like potholes or broken sidewalks linked to sharp decreases in road safety and quality of life for nearby residents. Given widespread reliance on transportation infrastructure makes examination of the governance structures underpinning its funding an important area of consideration.

Process-Shaping Priorities and the Federal Level

At the federal level, transportation infrastructure is primarily governed by the United States Department of Transportation (USDOT), an executive branch agency split into nine main operating administrations overseeing a specific part of the national transit system. USDOT then uses this oversight to distribute federal funding and ensure that individual transit outlets comply with national policy and safety standards. Distributed federal funding is drawn from the Highway Trust Fund, a dedicated federal fund financed through taxes on gas and other transportation costs, and distributed to states through formula-based approaches or competitive grant programs based on spending caps established by Congress. While federal funding plays an important role in transportation infrastructure, it only represents one-quarter of all public spending on roads and highways. The remaining three-quarters of long-term financing and associated maintenance is provided by state and local governments.

Keep ReadingShow less
Capitol Building in Washington, DC
white concrete building under blue sky during daytime

The Public Is Demanding Ethics Reform. Will Congress Listen?

At the end of the 2026 midterm elections, “corruption” emerged as a central issue in the campaign. The public outrage had been building for years. In a September 2026 Gallup poll, 89 percent of Americans agreed that corruption is “widespread throughout the government,” an all-time high. Allegations that members of Congress use insider information for stock trading have become a common belief. Additionally, a raft of sexual harassment and sexual assault scandals has shed light on the inadequate protections in place for congressional employees. As the 120th Congress convenes in January, Congress must respond to this national cry for ethics reform in the legislative and executive branches.

Historically, Congress has always needed a scandal to act. The Honest Government and Open Leadership Act of 2007 – famously proclaimed by Speaker Nancy Pelosi as an act to “drain the swamp” – was passed as a result of the lobbyist Jack Abramoff scandal involving illegal gifts and favors to members of Congress. It appears the swamp was harder to drain than anticipated.

Keep ReadingShow less
a piece of paper cut out of the shape of a donkey
a piece of paper cut out of the shape of a donkey
Photo by Kelly Sikkema on Unsplash

America Adrift—Our Future Depends on Returning to American Principles and Standards

The Democratic Party won the recent midterm elections overwhelmingly. But this was not because voters returned to the way people—whether Republican or Democrat— used to think about government and their relationship with it.

It was simply a matter of people being fed up with ever-increasing prices and with the Iran War. It was not a rejection of Trump's vicious, narcissistic, megalomaniac, mendacious personality nor his anti-democratic actions.

Keep ReadingShow less
Woman sleeping on the floor in a detention center

Woman sleeping on the floor in a detention center

Getty Images

Who Benefits When the Process Fails?

In my previous article, I wrote about TK, a lawful permanent resident who has lived in the US for 61 years and now faces possible deportation. I questioned whether immigration enforcement could coexist with fairness, compassion, and respect for the lives people have built in this country.

Since then, I have learned something equally troubling. The legal proceedings are only part of the ordeal. What happens outside the courtroom can be just as devastating.

Keep ReadingShow less